Oakland University’s most common major is focused on nursing and healthcare sciences. It has been a couple of years since the ...

The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...

On the other hand, recent history suggests that pharma-related topics like drug pricing are one of the few areas where bipartisan legislation is still possible. Drug pricing: The Inflation ...

HR Pharma has filed for a prescription to OTC switch for Opill, a decades-old daily progestin-only pill, just a few weeks after its $2 billion takeover by Ireland-headquartered Perrigo was completed.

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery or injuries. This photo provided by Vertex Pharmaceuticals in January 2025 ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

President Trump on Friday vowed to impose sweeping tariffs on semiconductor chips, pharmaceuticals, steel and aluminum and oil and gas. “We’ll be doing pharmaceuticals. Importantly in drugs ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...

semiconductors and pharmaceuticals in a push to increase U.S. production of the products. Trump announced the moves during remarks at a congressional Republican treat at the Trump National Doral ...